---
title: "Green Plains earnings: What to look for from GPRE"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294904912.md"
description: "Biorefining company Green Plains (NASDAQ: GPRE) is set to report earnings this Thursday. Last quarter, the company missed revenue expectations with $445.8 million in sales, a 25.9% year-over-year decline. However, it exceeded EPS estimates, marking a strong performance in profitability despite lower top-line figures."
datetime: "2026-08-05T03:32:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294904912.md)
  - [en](https://longbridge.com/en/news/294904912.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294904912.md)
generator: "portal-rs"
---

# Green Plains earnings: What to look for from GPRE

Biorefining company Green Plains (NASDAQ:GPRE) will be reporting earnings this Thursday morning. Here’s what you need to know. Green Plains missed analysts’ revenue expectations last quarter, reporting revenues of $445.8 million, down 25.9% year on year. It was a very strong quarter for the company, with a beat of analysts’ EPS estimates and an imp...

### Related Stocks

- [GPRE.US](https://longbridge.com/en/quote/GPRE.US.md)

## Related News & Research

- [BlackRock Inc. Invests $156.70 Million in Green Plains, Inc. $GPRE](https://longbridge.com/en/news/297395301.md)
- [Green Plains Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions](https://longbridge.com/en/news/295329576.md)
- [Quest Diagnostics teams with Humanity to offer biological age analysis on Questhealth.com](https://longbridge.com/en/news/296926398.md)
- [11:00 ETCizzle Bio Highlights CIZ1B Biomarker Blood Test for Lung Cancer at Next Generation Dx Summit](https://longbridge.com/en/news/297064751.md)
- [BARRA: Net loss halved and biological risks reduced, but revenue declined amid ongoing strategic transformation](https://longbridge.com/en/news/297340993.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**